Related Experiment Video
Updated: Jan 8, 2026
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
13.2K
Extracorporeal hemoperfusion as an adjunctive therapy for liver failure
Navid Shafigh1, Ameneh Jafari2, Haleh Alipour3
1Department of Anesthesiology and Critical Care Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Summary
Hemoperfusion using HA330 cartridges shows promise as supportive therapy for liver failure patients awaiting transplantation. This extracorporeal blood purification method may help manage toxins during acute decompensation, but further research is needed.
Area of Science:
- Hepatology
- Biomedical Engineering
- Critical Care Medicine
Background:
- Liver failure, a critical condition often leading to acute-on-chronic liver failure (ACLF), presents significant management challenges due to toxin accumulation and multi-system dysfunction.
- Liver transplantation is the definitive treatment, but patient management during acute decompensation requires supportive therapies to mitigate complications.
- Artificial liver support systems, including extracorporeal blood purification, offer potential adjunctive treatments to conventional medical care.
Purpose of the Study:
- To evaluate the use of HA330 hemoperfusion as an adjunctive therapy for patients with liver failure.
- To assess the potential benefits of extracorporeal blood purification in managing hepatic toxins and inflammatory mediators in liver failure patients.
Main Methods:
- A case series involving liver failure patients treated at a single center between 2023 and 2024.
- Application of HA330 hemoperfusion (Jafron, China) using an adsorptive cartridge as part of standard care.
- Monitoring of patient outcomes to determine the safety and efficacy of hemoperfusion as supportive therapy.
Main Results:
- Hemoperfusion with HA330 was employed as an adjunctive strategy alongside standard medical therapy for liver failure.
- Preliminary findings suggest hemoperfusion may be a beneficial supportive measure for patients with liver failure.
- The study provides initial data on the application of this specific hemoperfusion technology in a clinical setting.
Conclusions:
- HA330 hemoperfusion demonstrates potential as a valuable supportive therapy for liver failure patients, particularly those awaiting liver transplantation.
- Extracorporeal blood purification via hemoperfusion may aid in managing the acute decompensation phase of liver failure.
- Larger cohort studies are essential to conclusively establish the safety and efficacy of HA330 hemoperfusion in liver failure management.
Related Concept Videos
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
175
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
175
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
354
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
354
01:22Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
01:26Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
163
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
163
01:25Hemodialysis I: Introduction
1.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.2K